Isoptine L.P.

Verapamil Hydrochloride, the active ingredient in Isoptine L.P., is a calcium channel blocker presented as an oral dosage form for oral use. It is employed to manage hypertension, angina pectoris, and certain cardiac arrhythmias in adult patients, under medical supervision, and may be combined with other therapies as directed by a physician.

GNH USA supplies Isoptine L.P. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and timely delivery.

Verapamil Hydrochloride is used to treat cardiovascular conditions that involve excessive calcium influx into cardiac and vascular smooth muscle. - Hypertension: reduces peripheral vascular resistance and lowers blood pressure. - Angina pectoris: decreases myocardial oxygen demand by lowering heart rate and contractility. - Cardiac arrhythmias: stabilizes cardiac rhythm by slowing conduction through the AV node.

Verapamil Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Dizziness: sensation of light‑headedness or vertigo. - Headache: mild to moderate cranial pain. - Peripheral edema: fluid accumulation in the lower extremities. - Flushing: transient redness and warmth of the skin. - Nausea: upset stomach with possible vomiting.

Serious or Rare Side Effects: - Bradycardia: markedly slowed heart rate that may require medical attention. - Severe hypotension: sudden and significant drop in blood pressure. - AV block: impaired atrioventricular conduction that can lead to syncope. - Heart failure exacerbation: worsening of pre‑existing cardiac insufficiency. - Hepatic enzyme elevation: abnormal liver function test results.

When prescribing Verapamil Hydrochloride, clinicians should consider several safety measures to minimize risks. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess cardiac function: evaluate heart rate and ECG for bradyarrhythmias. - Use caution in hepatic impairment: dose adjustments may be needed. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia. - Review concomitant medications: consider potential drug interactions. - Store at ambient temperature: keep in original container, protect from moisture and light.

Verapamil Hydrochloride interacts with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Beta‑blockers: additive bradycardia and AV block. - Digoxin: increased serum digoxin levels leading to toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): raise verapamil concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce verapamil effectiveness. - Diuretics: may enhance hypotensive effect. - Lithium: increased lithium levels and risk of toxicity.